Lessa Fernanda, Tak Sangwoo, Devader Shannon R, Goswami Rekha, Anderson Mary, Williams Ian, Gensheimer Kathleen F, Srinivasan Arjun
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia 30333, USA.
Infect Control Hosp Epidemiol. 2008 Apr;29(4):289-93. doi: 10.1086/533546.
A hospital discovered a lapse in the reprocessing procedures for transrectal ultrasound-guided prostate biopsy equipment. An investigation was initiated to assess the risks of transmission of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and bacteria during prostate biopsies.
We offered testing for HBV, HCV, and HIV infection to patients who had undergone prostate biopsies from January 30, 2003, through January 27, 2006. We reviewed their medical records and obtained information on the reprocessing procedures that were in use at the time for the prostate biopsy equipment.
A healthcare facility in Maine.
Of the 528 patients exposed to improperly reprocessed prostate biopsy equipment, none tested positive for HIV or HCV. Sixteen patients (3%) tested positive for past HBV infection but had no prebiopsy HBV serologic test results available (ie, transmission from improperly reprocessed biopsy equipment was possible), and 11 (2%) had evidence of postbiopsy bacterial infections. The number of cases of HBV and bacterial infections were within reported ranges for this population and were not clustered in time. Review of the reprocessing procedures in use at the time revealed that the manufacturer-recommended brushes for cleaning the reusable biopsy needle guide were never used. Brushes did not come with the equipment and had to be ordered separately.
Despite the lack of evidence of pathogen transmission in this investigation, it is critical to review the manufacturer's reprocessing recommendations and to establish appropriate procedures to avert potential pathogen transmission and subsequent patient concerns. This investigation provides a better understanding of the risks associated with improperly reprocessed transrectal ultrasound prostate biopsy equipment and serves as a methodologic tool for future investigations.
一家医院发现经直肠超声引导前列腺活检设备的再处理程序存在失误。于是展开调查,以评估前列腺活检过程中乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)、人类免疫缺陷病毒(HIV)及细菌传播的风险。
我们为2003年1月30日至2006年1月27日期间接受过前列腺活检的患者提供HBV、HCV及HIV感染检测。我们查阅了他们的病历,并获取了当时前列腺活检设备所采用的再处理程序的相关信息。
缅因州的一家医疗机构。
在528名接触过再处理不当的前列腺活检设备的患者中,无人HIV或HCV检测呈阳性。16名患者(3%)既往HBV感染检测呈阳性,但活检前无HBV血清学检测结果(即可能因活检设备再处理不当而传播),11名患者(2%)有活检后细菌感染的证据。HBV和细菌感染病例数在该人群报告范围内,且未呈时间聚集性。对当时使用的再处理程序的审查显示,从未使用过制造商推荐的用于清洁可重复使用活检针导的刷子。刷子未随设备配备,必须单独订购。
尽管本次调查缺乏病原体传播的证据,但审查制造商的再处理建议并建立适当程序以避免潜在的病原体传播及后续患者担忧至关重要。本次调查有助于更好地了解经直肠超声前列腺活检设备再处理不当相关的风险,并为未来调查提供了一种方法学工具。